Take a look inside Riverside’s EP lab, where the first LASSO™ mapping catheter-guided pulmonary vein isolation procedure to ablate focal atrial fibrillation was performed in the United States. They were also the second in the country to implant an epicardial bi-ventricular pacemaker. Riverside maintains a fast daily pace, performing over 7,000 cases annually. They currently have 2 noninvasive labs and 4 invasive labs, and are opening a fifth invasive lab this summer.